Search Results 431-440 of 2272 for 搜索留痕怎么做咨询邮箱:lgooxc@hotmail.com
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Abhishek A. Mangaonkar, M.B.B.S., studies the immune microenvironment of myeloid cancers and bone marrow failure syndromes.
Contact the Hospital Experiences to Advance Goals and Outcomes Network (HEXAGON) at Mayo Clinic with questions about research resources or collaboration.
All patients who complete the 52-week double-blind treatment period on IP may be eligible to continue into an open label extension (OLE) period. The OLE period ...
About this study. The purpose of this is to study wearables for assessing nontechnical and technical skills (WeNOTES) in the porcine lab that may ultimately ...
The purpose of this study is to result in adaptable, minimally tailored virtual human technology (VHT) recruitment intervention for increasing older adult ...
Patients in this study will be allowed treatment with stable doses of oral aminosalicylates, oral corticosteroids, immunosupressants and antibiotics for the ...
The primary objective of this study is to collect real-world clinical performance data to assess the clinical outcomes of patients receiving heart transplants ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.